[1]
S. Ahmad, M. Zaman, N. Idrees, R. Gul, Y. Aziz, and F. Ahmad, “Evaluation of the Efficacy of Rifaximin versus Mebeverine in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: Rifaximin versus Mebeverine in the Treatment of Diarrhea-Predominant IBS”, PJHS-Lahore, vol. 7, no. 3, pp. 124–130, Mar. 2026.